Botanical species · safety record

Phaseolus vulgaris

The EFSA Compendium of Botanicals holds 5 constituent measurements and 3 adverse-effect records for Phaseolus vulgaris. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Phaseolus vulgaris L.

5Constituent measurements
3Safety records
7Cited sources
198Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 198 licensed products naming Phaseolus vulgaris as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

  • Dry
  • Extract Type TBA
  • Fresh

Source material stated

  • Bean
  • Bean Extract
  • Fruit
  • Fruit Shell
  • Fruit pericarp
  • Leaf and stem
  • Phaseolamin
  • Phaseolus vulgaris - Seed

What the records describe

Constituents measured

  • Tannins4
  • Phasin1

Plant parts

  • Seed7
  • Unspecified1

Preparations

  • Solvent extraction4

Effect types

  • Digestive2

Target tissues

  • Digestive2
  • Stomach1

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
PhasinUnspecifiedUnspecifiedResolve DOI
TanninsSeedSolvent extraction≥ 59.74 Milligram/gramColorimetry, Spectroscopy (Spectrometry) and PhotometryResolve DOI
TanninsSeedSolvent extraction≥ 586 Milligram/gramColorimetry, Spectroscopy (Spectrometry) and PhotometryResolve DOI
TanninsSeedSolvent extraction≤ 859.84 Milligram/gramColorimetry, Spectroscopy (Spectrometry) and PhotometryResolve DOI
TanninsSeedSolvent extraction≤ 222.41 Milligram/gramColorimetry, Spectroscopy (Spectrometry) and PhotometryResolve DOI

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

EffectTarget tissuePlant partPreparationTest organismTest typeSource
Not statedDigestiveSeedHuman (as organism)Not reportedResolve DOI
DigestiveDigestiveSeedHuman (as organism)Case reportNo resolvable identifier
DigestiveStomachSeedCattle (as animal)Not reportedNo resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Assis, T.S., Medeiros, R.M., de Ara�jo, J.A.S., Dantas, A.F.M., Riet-Correa, F. Plant poisonings in ruminants and equidae in the Sert�o of Paraiba, Brazil Intoxica��es por plantas em ruminantes e equ�deos no Sert�o Paraibano. Pesquisa veterinaria brasileira, 2009, vol. 29, no. 11, p. 919-924.
  2. Kuete, V. Physical, Hematological, and Histopathological Signs of Toxicity Induced by African Medicinal Plants. Toxicological survey of african medicinal plants, 2014, p. 635-657. DOI
  3. Tuxen, M K., Nielsen, H V., Birgens, H. Poisoning by kidney beans (Phaseolus vulgaris) .. Ugeskrift for laeger, 1991, vol. 153, no. 51, p. 3628-9.
  4. Jayne-Williams, D. J., Burgess, C. D. Toxicity of navy beans (Phaseolus vulgaris) for Japanese quail (Coturnix coturnix). Journal of applied bacteriology, 1974, vol. 37, no. 1, p. 149-69.
  5. Aparicio-Fernandez, X., Manzo-Bonilla, L., Loarca-Pina, GF. Comparison of antimutagenic activity of phenolic compounds in newly harvested and stored common beans Phaseolus vulgaris against aflatoxin B1. Journal of food science, 2005, vol. 70, no. 1, p. S73-S78. DOI
  6. Kupper, Jacqueline., Reichert, Cornelia. Intoxications with plants .. Therapeutische umschau. revue therapeutique, 2009, vol. 66, no. 5, p. 343-8. DOI
  7. Liener, I E. Naturally occurring toxicants in foods and their significance in the human diet.. Archives of toxicology. supplement. = archiv fur toxikologie. supplement, 1983, vol. 6, p. 153-66.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue